Cite
Immunotherapy in MMR-d/MSI-H recurrent/metastatic endometrial cancer.
MLA
Pacholczak-Madej, Renata, et al. “Immunotherapy in MMR-d/MSI-H Recurrent/Metastatic Endometrial Cancer.” Expert Review of Anticancer Therapy, vol. 24, no. 8, Aug. 2024, pp. 717–29. EBSCOhost, https://doi.org/10.1080/14737140.2024.2367472.
APA
Pacholczak-Madej, R., Bartoletti, M., Musacchio, L., Püsküllüoglu, M., Blecharz, P., & Lorusso, D. (2024). Immunotherapy in MMR-d/MSI-H recurrent/metastatic endometrial cancer. Expert Review of Anticancer Therapy, 24(8), 717–729. https://doi.org/10.1080/14737140.2024.2367472
Chicago
Pacholczak-Madej, Renata, Michele Bartoletti, Lucia Musacchio, Mirosława Püsküllüoglu, Paweł Blecharz, and Domenica Lorusso. 2024. “Immunotherapy in MMR-d/MSI-H Recurrent/Metastatic Endometrial Cancer.” Expert Review of Anticancer Therapy 24 (8): 717–29. doi:10.1080/14737140.2024.2367472.